Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00184730
Status:
COMPLETED
Last Update Posted:
2016-11-17
First Post:
2005-09-13
Brief Title:
Long-term Trial on Growth Hormone Deficiency in Adults GHDA
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
Investigation of the Efficacy and Safety of hGH in Long Term More Than 48 Weeks in GHDA
Status:
COMPLETED
Status Verified Date:
2016-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is conducted in Japan This protocol describes an extension trial to supply hGH to subjects who wish continuous treatment after the long-term Phase 3 trial GHLiquid-1519 until hGH products have been approved for GHDA in Japan
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| JapicCTI-050134 | REGISTRY | japic | None |